What is the price-to-earnings ratio of Chromadex?
The price-earnings ratio of Chromadex is currently 2.56.
Chromadex P/S 2024
Chromadex P/S
2.56
Chromadex Dividend yield
Ticker
CDXC
ISIN
US1710774076
WKN
A2AG5N
As of Apr 25, 2024, Chromadex's P/S ratio stood at 2.56, a 91.04% change from the 1.34 P/S ratio recorded in the previous year.
The Chromadex P/S history
Chromadex Aktienanalyse
What does Chromadex do?
The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Chromadex ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Chromadex's P/S Ratio
Chromadex's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Chromadex's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Chromadex's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Chromadex’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Chromadex Stock
How has the price-earnings ratio of Chromadex changed compared to last year?
The price-to-earnings ratio of Chromadex has increased by 91.04% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Chromadex high compared to other companies?
Yes, the price-to-earnings ratio of Chromadex is high compared to other companies.
How does an increase in the price-earnings ratio of Chromadex affect the company?
An increase in the price-earnings ratio of Chromadex would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Chromadex affect the company?
A decrease in the price-earnings ratio of Chromadex would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Chromadex?
Some factors that influence the price-earnings ratio of Chromadex are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Chromadex pay?
Over the past 12 months, Chromadex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chromadex is expected to pay a dividend of 0 USD.
What is the dividend yield of Chromadex?
The current dividend yield of Chromadex is .
When does Chromadex pay dividends?
Chromadex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Chromadex?
Chromadex paid dividends every year for the past 0 years.
What is the dividend of Chromadex?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Chromadex located?
Chromadex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Chromadex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Chromadex from 4/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/25/2024.
When did Chromadex pay the last dividend?
The last dividend was paid out on 4/25/2024.
What was the dividend of Chromadex in the year 2023?
In the year 2023, Chromadex distributed 0 USD as dividends.
In which currency does Chromadex pay out the dividend?
The dividends of Chromadex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Chromadex stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Chromadex
Our stock analysis for Chromadex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chromadex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
